2023年赛国生物取得北京博奥森生物一级代理权。

        成立于2001年，北京博奥森生物技术有限公司有2000万元注册资本，是集免疫学科研试剂研发、生产、售为体的国家高新技术企业。在公司近1300平米的研发中心楼内，拥有SPF级实验动物房、GMP级单克隆抗体制备平台，同时购置了CSBio多肽合成仪、Akta全自动液相色谱系统、BD流式细胞仪、Leica冷冻切片机等多种生产、检测仪器。公司还拥有一批技术精湛、经验丰富的科研发团队，在免疫和分子生物学等领域拥有多项自主知识产权。

        自成立之初，公司始终秉持“自主研发、原始创新，为全球生命科学研究提供优质服务”的经营理念。提供全面的科研抗体、试剂，诊断抗体原料，以及CRO服务。公司现拥有近两万种抗体产品，涵盖人蛋白靶点13000多个。特色产品有特异磷酸化抗体及专利授权AF荧光标记抗体等。此外，公司还提供完善的单/多克隆抗体制备、标记、重组蛋白、多肽合成及各项免疫学检测技术服务等。公司恪守ISO9001:2008国际质量管理体系认证要求，致力于打造“Bioss”精品抗体品牌。 2010年博奥森（波士顿）在美国设立了面向全球抗体市场的商务拓展及国际市场营总部，不断扩展全球售体系，主打Bioss国际品牌，向全球科研工作者提供高质量的科研抗体产品。迄今为止，Bioss产品已遍布全球多个国家和地区，并已成为数家国际知名抗体公司的OEM合作伙伴。Bioss抗体产品已出现在数千篇高质量SCI文章中，获得了全世界众多生命科学领域科研人员的认可。

       百舸争流，只争朝夕。近二十年的探索和拼搏，为Bioss品牌在免疫学试剂领域奠定了坚实的基础。我们将在未来勇于拓，自主创新，为生命科学研究提供更加优质的产品和服务，回报全球用户的信任，为生命科学进步尽绵薄之力。

       In 2023, Saiguo Biotech obtained the first-class agent right of Beijing Bioss.

      Established in 2001, Beijing Biossen Biotechnology Co., Ltd. has a registered capital of 20 million RMB and is a national high-tech enterprise integrating R&D, production and sales of immunology research reagents. In the company's R&D center building of nearly 1300 square meters, we have SPF-grade laboratory animal room, GMP-grade monoclonal antibody preparation platform, and we have also purchased a variety of production and testing instruments such as CSBio peptide synthesizer, Akta automatic liquid chromatography system, BD flow cytometer and Leica frozen section machine. The company also has a group of skilled and experienced research and development team, and owns a number of independent intellectual property rights in the fields of immunology and molecular biology.

     Since its inception, the company has been upholding the business philosophy of "independent research and development, original innovation, and providing quality services for global life science research". We provide a comprehensive range of research antibodies, reagents, diagnostic antibody materials and CRO services. The company now has nearly 20,000 antibody products, covering more than 13,000 human protein targets. Featured products include specific phosphorylated antibodies and patent-licensed AF fluorescence labeled antibodies. In addition, the company also provides complete mono/polyclonal antibody preparation, labeling, recombinant protein, peptide synthesis and various immunological assay technology services. The company adheres to the requirements of ISO9001:2008 international quality management system certification, and is committed to building the "Bioss" brand of high-quality antibodies. In 2010, Bioss (Boston) set up its business development and international marketing headquarters in the United States for the global antibody market, expanding its global sales system, and providing high-quality research antibody products to researchers worldwide under the Bioss international brand. Bioss antibody products have been featured in thousands of high-quality SCI articles and are recognized by researchers in the life science field worldwide.

       A hundred boats are competing for each other, and it is only a matter of time. Nearly two decades of exploration and hard work have laid a solid foundation for the Bioss brand in the field of immunology reagents. In the future, we will be brave to develop and innovate independently to provide more high-quality products and services for life science research, to repay the trust of global users, and to do our best for the progress of life science.

【2022/12/28 15:16:10】